Citations (138)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Charlotte Sorieul, Marta Dolce, Maria Rosaria Romano, Jeroen Codée & Roberto Adamo. (2023) Glycoconjugate vaccines against antimicrobial resistant pathogens. Expert Review of Vaccines 22:1, pages 1055-1078.
Read now
Read now
Ali Qasemi, Fateh Rahimi & Mohammad Katouli. (2022) Clonal groups of extended-spectrum β-lactamase and biofilm producing uropathogenic Escherichia coli in Iran. Pathogens and Global Health 116:8, pages 485-497.
Read now
Read now
Alison J. Carey, Chee K. Tan, Deepak S. Ipe, Matthew J. Sullivan, Allan W. Cripps, Mark A. Schembri & Glen C. Ulett. (2016) Urinary tract infection of mice to model human disease: Practicalities, implications and limitations. Critical Reviews in Microbiology 42:5, pages 780-799.
Read now
Read now
Martino Maria Zacchè & Ilias Giarenis. (2016) Therapies in early development for the treatment of urinary tract inflammation. Expert Opinion on Investigational Drugs 25:5, pages 531-540.
Read now
Read now
Hanna E Sidjabat & David L Paterson. (2015) Multidrug-resistant Escherichia coli in Asia: epidemiology and management. Expert Review of Anti-infective Therapy 13:5, pages 575-591.
Read now
Read now
Phillip Cash. (2014) Proteomic analysis of uropathogenic Escherichia coli
. Expert Review of Proteomics 11:1, pages 43-58.
Read now
Read now
Articles from other publishers (132)
Andrew N. Rycroft. 2023. Fundamentals of Veterinary Microbiology. Fundamentals of Veterinary Microbiology
69
73
.
Juan Xicohtencatl-Cortes, Sara A. Ochoa, Ariadnna Cruz-Córdova, Marco A. Flores-Oropeza & Rigoberto Hernández-Castro. 2023. Urinary Tract Infections - New Insights. Urinary Tract Infections - New Insights.
Anne-Gaëlle Goubet, Mathieu Rouanne, Lisa Derosa, Guido Kroemer & Laurence Zitvogel. (2023) From mucosal infection to successful cancer immunotherapy. Nature Reviews Urology 20:11, pages 682-700.
Crossref
Crossref
C. T. Dhanya Raj, Krishnan Muthukumar, Hans Uwe Dahms, Rathinam Arthur James & Surabhi Kandaswamy. (2023) Structural characterization, antioxidant and anti-uropathogenic potential of biogenic silver nanoparticles using brown seaweed Turbinaria ornata. Frontiers in Microbiology 14.
Crossref
Crossref
Abdulaziz H. Alhazmi, Khalid M. Alameer, Bandar M. Abuageelah, Rena H. Alharbi, Mousa Mobarki, Shaqraa Musawi, Moayad Haddad, Abdullatif Matabi & Nabil Dhayhi. (2023) Epidemiology and Antimicrobial Resistance Patterns of Urinary Tract Infections: A Cross-Sectional Study from Southwestern Saudi Arabia. Medicina 59:8, pages 1411.
Crossref
Crossref
Ricardo Monteiro, Ingrid Chafsey, Nelly Caccia, Valentin Ageorges, Sabine Leroy, Didier Viala, Michel Hébraud, Valérie Livrelli, Mariagrazia Pizza, Alfredo Pezzicoli & Mickaël Desvaux. (2023) Specific Proteomic Identification of Collagen-Binding Proteins in Escherichia coli O157:H7: Characterisation of OmpA as a Potent Vaccine Antigen. Cells 12:12, pages 1634.
Crossref
Crossref
Maryam Rezaei, Fariba Esmaeili, Mohammad Reza Asadi Karam, Parastoo Ehsani, Zeinab Abbasnezhad Farsangi & Saeid Bouzari. (2023) In silico design and in vivo evaluation of two multi-epitope vaccines containing build-in adjuvant with chitosan nanoparticles against uropathogenic Escherichia coli. International Immunopharmacology 117, pages 109999.
Crossref
Crossref
María del Carmen Santomil Ponte, Ernesto José González Veiga, Aroa Mayán Taboada, Estefanía Rodríguez Romero & Enrique Nieto Pol. (2023) Infecciones del tracto urinario de repetición. FMC - Formación Médica Continuada en Atención Primaria 30:2, pages 90-96.
Crossref
Crossref
Pooi Yin Chung. (2023)
Immunotherapies for the prevention and treatment of
Staphylococcus aureus
infections: updates and challenges
. Pathogens and Disease 81.
Crossref
Crossref
Sheida Hedayat, Mehri Habibi, Reza Hosseini Doust & Mohammad Reza Asadi Karam. (2023) Design of a chimeric protein composed of FimH, FyuA and CNF-1 virulence factors from uropathogenic Escherichia coli and evaluation its biological activity and immunogenicity in vitro and in vivo. Microbial Pathogenesis 174, pages 105920.
Crossref
Crossref
LiangZhe Liu, Carmen Oi Kwan Law, Qichang Nie, Hoa Quynh Pham, Haiying Ma, Liang Zhang, Pak Leung Ho & Terrence Chi-Kong Lau. (2023) Comparative analysis of outer membrane vesicles from uropathogenic Escherichia coli reveal the role of aromatic amino acids synthesis proteins in motility. International Journal of Medical Microbiology 313:1, pages 151573.
Crossref
Crossref
Yazdan Shabani, Hajar Sadeghi, Parsa Yousefichaijan, Davoud Shabani & Fatemeh Rafiee. (2022) Prevalence of Risk Factors of Urinary Tract Infections in Infants and Children in Arak, Iran: A Cross-sectional Study. Nephro-Urology Monthly 15:1.
Crossref
Crossref
Sean H. Kelly, Nicole L. Votaw, Benjamin J. CossetteYaoying Wu, Shamitha Shetty, Lucas S. Shores, Luqman A. IssahJoel H. Collier. (2022) A sublingual nanofiber vaccine to prevent urinary tract infections. Science Advances 8:47.
Crossref
Crossref
Jeroen Geurtsen, Mark de Been, Eveline Weerdenburg, Aldert Zomer, Alan McNally & Jan Poolman. (2022)
Genomics and pathotypes of the many faces of
Escherichia coli
. FEMS Microbiology Reviews 46:6.
Crossref
Crossref
Evgeni V. Sokurenko, Veronika Tchesnokova, Gianluca Interlandi, Rachel Klevit & Wendy E. Thomas. (2022) Neutralizing Antibodies Against Allosteric Proteins: Insights From a Bacterial Adhesin. Journal of Molecular Biology 434:17, pages 167717.
Crossref
Crossref
Colin J. Worby, Benjamin S. Olson, Karen W. Dodson, Ashlee M. Earl & Scott J. Hultgren. (2022) Establishing the role of the gut microbiota in susceptibility to recurrent urinary tract infections. Journal of Clinical Investigation 132:5.
Crossref
Crossref
Allyson E. Shea, Jolie A. Stocki, Stephanie D. Himpsl, Sara N. Smith & Harry L. T. Mobley. (2022) Loss of an Intimin-Like Protein Encoded on a Uropathogenic E. coli Pathogenicity Island Reduces Inflammation and Affects Interactions with the Urothelium. Infection and Immunity 90:2.
Crossref
Crossref
Luciano Garofalo, Claudia Nakama, Douglas Hanes & Heather Zwickey. (2022) Whole-Person, Urobiome-Centric Therapy for Uncomplicated Urinary Tract Infection. Antibiotics 11:2, pages 218.
Crossref
Crossref
Jin Zou, Bo Peng, Jiuxin Qu & Jun Zheng. (2022) Are Bacterial Persisters Dormant Cells Only?. Frontiers in Microbiology 12.
Crossref
Crossref
Puneet Kaur, Rohan Samir Kumar Sachan, Arun Karnwal & Inderpal Devgon. (2022) A Review on Clinical Manifestation and Treatment Regimens of UTI in Diabetic Patients. Iranian Journal of Medical Microbiology 16:2, pages 98-115.
Crossref
Crossref
Mohammad Reza Asadi Karam, Farzad Badmasti, Khadijeh Ahmadi & Mehri Habibi. (2022) Vaccination of mice with hybrid protein containing Exotoxin S and PcrV with adjuvants alum and MPL protects Pseudomonas aeruginosa infections. Scientific Reports 12:1.
Crossref
Crossref
Azardokht Tabatabaie, Ali Badamchi, Elnaz Ohadi, Atieh Darbandi, Shima Javadinia, Sara Minaeian, Mehri Naghdalipour & Behnam Sobouti. (2022) Determination of virulence and quinolone resistance genes and biofilm production among uropathogenic Escherichia coli strains isolated from clinical specimens in Iran. Reviews in Medical Microbiology 33:1, pages 20-30.
Crossref
Crossref
Miri Hyun, Ji Yeon Lee & Hyun ah Kim. (2021) Differences of virulence factors, and antimicrobial susceptibility according to phylogenetic group in uropathogenic Escherichia coli strains isolated from Korean patients. Annals of Clinical Microbiology and Antimicrobials 20:1.
Crossref
Crossref
Jennifer Jones, Craig P. Murphy, Roy D. Sleator & Eamonn P. Culligan. (2021) The urobiome, urinary tract infections, and the need for alternative therapeutics. Microbial Pathogenesis 161, pages 105295.
Crossref
Crossref
Marta Faggian, Giulia Bernabè, Marco Valente, Stefano Francescato, Gianni Baratto, Paola Brun, Ignazio Castagliuolo, Stefano Dall'Acqua & Gregorio Peron. (2021) Characterization of PACs profile and bioactivity of a novel nutraceutical combining cranberry extracts with different PAC-A oligomers, D-mannose and ascorbic acid: An in vivo/ex vivo evaluation of dual mechanism of action on intestinal barrier and urinary epithelium. Food Research International 149, pages 110649.
Crossref
Crossref
Matilde Durán-Lobato, Ana María López-Estévez, Ana Sara Cordeiro, Tamara G. Dacoba, José Crecente-Campo, Dolores Torres & María José Alonso. (2021) Nanotechnologies for the delivery of biologicals: Historical perspective and current landscape. Advanced Drug Delivery Reviews 176, pages 113899.
Crossref
Crossref
Ulises Hernández-Chiñas, María E. Chávez-Berrocal, Ricardo E. Ahumada-Cota, Armando Navarro-Ocaña, Luz M. Rocha-Ramírez, Yolanda Pérez-del Mazo, Maribel Alvarado-Cabello, Gabriel Pérez-Soto, Luis A. León-Alamilla, Salvador E. Acevedo-Monroy, Diego Esquiliano, Atlántida M. Raya-Rivera & Carlos A. Eslava. (2021) Prospective Study in Children with Complicated Urinary Tract Infection Treated with Autologous Bacterial Lysates. Microorganisms 9:9, pages 1811.
Crossref
Crossref
Ian Cock, Nothando Mavuso & Sandy Van Vuuren. (2021) A Review of Plant-Based Therapies for the Treatment of Urinary Tract Infections in Traditional Southern African Medicine. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-20.
Crossref
Crossref
J. R. Clark & A. M. Maresso. (2021)
Comparative Pathogenomics of
Escherichia coli
: Polyvalent Vaccine Target Identification through Virulome Analysis
. Infection and Immunity 89:8.
Crossref
Crossref
Mehri Habibi, Saba Azimi, Dorna Khoobbakht, Pooneh Roghanian & Mohammad Reza Asadi Karam. (2021) Immunization with recombinant protein Ag43::UpaH with alum and 1,25(OH)2D3 adjuvants significantly protects Balb/C mice against urinary tract infection caused by uropathogenic Escherichia coli. International Immunopharmacology 96, pages 107638.
Crossref
Crossref
Jianxuan Wu, Chunjing BaoR. Lee Reinhardt & Soman N. Abraham. (2021) Local induction of bladder Th1 responses to combat urinary tract infections. Proceedings of the National Academy of Sciences 118:10.
Crossref
Crossref
Jeong-Ju Yoo, Hee Shin, Ju Song, Minjung Kim, Jina Yun, Zisun Kim, Yoo Lee, Sang Lee, Kwang Lee, Woong Kim, Chang Ryu, Sung-Woo Park, Seong Park, Ho-Yeon Song & Young Kim. (2021) Urinary Microbiome Characteristics in Female Patients with Acute Uncomplicated Cystitis and Recurrent Cystitis. Journal of Clinical Medicine 10:5, pages 1097.
Crossref
Crossref
Jonathan Broad, Kirsty Le Doare, Paul T. Heath, Philippa Hallchurch, Isabelle Whelan, Hannah Boyd, Elspeth Carruthers, Mike Sharland & Shamez Ladhani. (2020) The current state of immunization against Gram-negative bacteria in children: a review of the literature. Current Opinion in Infectious Diseases 33:6, pages 517-529.
Crossref
Crossref
Sara Hasanzadeh, Mehri Habibi, Mohammad Ali Shokrgozar, Reza Ahangari Cohan, Khadijeh Ahmadi, Mohammad Reza Asadi Karam & Saeid Bouzari. (2020) In silico analysis and in vivo assessment of a novel epitope-based vaccine candidate against uropathogenic Escherichia coli. Scientific Reports 10:1.
Crossref
Crossref
Julia Harrer & Roswitha Dorsch. (2020) Bakterielle Harnwegsinfektion und subklinische Bakteriurie des Hundes: eine aktuelle Übersicht. Tierärztliche Praxis Ausgabe K: Kleintiere / Heimtiere 48:04, pages 270-284.
Crossref
Crossref
Livia Lacerda Mariano & Molly A. Ingersoll. (2020) The immune response to infection in the bladder. Nature Reviews Urology 17:8, pages 439-458.
Crossref
Crossref
Elie Saade, Stefan Gravenstein, Curtis J. Donskey, Brigid Wilson, Bart Spiessens, Darren Abbanat, Jan Poolman, Patricia Ibarra de Palacios & Peter Hermans. (2020) Characterization of Escherichia coli isolates potentially covered by ExPEC4V and ExPEC10V, that were collected from post-transrectal ultrasound-guided prostate needle biopsy invasive urinary tract and bloodstream infections. Vaccine 38:33, pages 5100-5104.
Crossref
Crossref
Sarah Prattley, Robert Geraghty, Michael Moore & Bhaskar K. Somani. (2020) Role of Vaccines for Recurrent Urinary Tract Infections: A Systematic Review. European Urology Focus 6:3, pages 593-604.
Crossref
Crossref
Jonathan NorthMark Jit & Ben Cooper. 2020. Challenges to Tackling Antimicrobial Resistance. Challenges to Tackling Antimicrobial Resistance
181
206
.
Jonathan North. 2020. Challenges to Tackling Antimicrobial Resistance. Challenges to Tackling Antimicrobial Resistance.
Siya Lodhia, Ala'a Sharaf & Charlotte Foley. (2020) Management of recurrent urinary tract infections in adults. Surgery (Oxford) 38:4, pages 197-203.
Crossref
Crossref
Soodabeh Derakhshandeh, Nader Shahrokhi, Vahid Khalaj, Mehri Habibi, Neda Moazzezy, Mohammad Reza Asadi Karam & Saeid Bouzari. (2020) Surface display of uropathogenic Escherichia coli FimH in Lactococcus lactis: In vitro characterization of recombinant bacteria and its protectivity in animal model. Microbial Pathogenesis 141, pages 103974.
Crossref
Crossref
Laurent Derré, Ilaria Lucca, Valérie Cesson, Massimo Valerio, Yannick Cerantola, Rodolfo Burruni, Urs Fritschi, Dalila Gharbi, Martine Bobst, Anne-Sophie Legris, Florence Dartiguenave, Patrice Jichlinski & Denise Nardelli-Haefliger. (2020) Intramuscular Immunization Induces Antigen-specific Antibodies in Urine. European Urology Focus 6:2, pages 280-283.
Crossref
Crossref
Ricardo E. Ahumada-Cota, Ulises Hernandez-Chiñas, Feliciano Milián-Suazo, María E. Chávez-Berrocal, Armando Navarro-Ocaña, Daniel Martínez-Gómez, Genaro Patiño-López, Erika P. Salazar-Jiménez & Carlos A. Eslava. (2020) Effect and Analysis of Bacterial Lysates for the Treatment of Recurrent Urinary Tract Infections in Adults. Pathogens 9:2, pages 102.
Crossref
Crossref
Sylwia Joanna Chmielewska & Katarzyna Leszczyńska. (2020)
The Role And Importance Of Selected Virulence Factors Determining The Pathogenicity Of Uropathogenic
Escherichia Coli
Strains
. Postępy Mikrobiologii - Advancements of Microbiology 59:1, pages 25-37.
Crossref
Crossref
Andreas Hamper, Lucas Neitzel, Nilmini Wickramasinghe & Freimut Bodendorf. 2020. Delivering Superior Health and Wellness Management with IoT and Analytics. Delivering Superior Health and Wellness Management with IoT and Analytics
3
39
.
Dhruba Acharya, Matthew J. Sullivan, Benjamin L. Duell, Kelvin G. K. Goh, Lahiru Katupitiya, Dean Gosling, Michelle N. Chamoun, Asha Kakkanat, Debasish Chattopadhyay, Michael Crowley, David K. Crossman, Mark A. Schembri & Glen C. Ulett. (2019) Rapid Bladder Interleukin-10 Synthesis in Response to Uropathogenic Escherichia coli Is Part of a Defense Strategy Triggered by the Major Bacterial Flagellar Filament FliC and Contingent on TLR5. mSphere 4:6.
Crossref
Crossref
Nadine Legros, Stefanie Ptascheck, Gottfried Pohlentz, Helge Karch, Ulrich Dobrindt & Johannes Müthing. (2019) PapG subtype-specific binding characteristics of Escherichia coli towards globo-series glycosphingolipids of human kidney and bladder uroepithelial cells. Glycobiology 29:11, pages 789-802.
Crossref
Crossref
Katarzyna M. Mickiewicz, Yoshikazu Kawai, Lauren Drage, Margarida C. Gomes, Frances Davison, Robert Pickard, Judith Hall, Serge Mostowy, Phillip D. Aldridge & Jeff Errington. (2019) Possible role of L-form switching in recurrent urinary tract infection. Nature Communications 10:1.
Crossref
Crossref
Christina A. Sarkissian, Christopher J. Alteri & Harry L.T. Mobley. (2019) UTI patients have pre-existing antigen-specific antibody titers against UTI vaccine antigens. Vaccine 37:35, pages 4937-4946.
Crossref
Crossref
Mohammad Reza Asadi Karam, Mehri Habibi & Saeid Bouzari. (2019) Urinary tract infection: Pathogenicity, antibiotic resistance and development of effective vaccines against Uropathogenic Escherichia coli. Molecular Immunology 108, pages 56-67.
Crossref
Crossref
José Antonio Ortega Martell, Kurt G. Naber, Jorge Milhem Haddad, José Tirán Saucedo & Jesús Alfonso Domínguez Burgos. (2019) Prevention of recurrent urinary tract infections: bridging the gap between clinical practice and guidelines in Latin America. Therapeutic Advances in Urology 11, pages 175628721882408.
Crossref
Crossref
Laura Barcán. 2019. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Néha Sihra, Anna Goodman, Rhana Zakri, Arun Sahai & Sachin Malde. (2018) Nonantibiotic prevention and management of recurrent urinary tract infection. Nature Reviews Urology 15:12, pages 750-776.
Crossref
Crossref
Thomas M. Hooton, Mariacristina Vecchio, Alison Iroz, Ivan Tack, Quentin Dornic, Isabelle Seksek & Yair Lotan. (2018) Effect of Increased Daily Water Intake in Premenopausal Women With Recurrent Urinary Tract Infections. JAMA Internal Medicine 178:11, pages 1509.
Crossref
Crossref
Mohammad Reza Asadi Karam, Mehri Habibi & Saeid Bouzari. (2018) Relationships between Virulence Factors and Antimicrobial Resistance among <italic>Escherichia coli</italic> Isolated from Urinary Tract Infections and Commensal Isolates in Tehran, Iran. Osong Public Health and Research Perspectives 9:5, pages 217-224.
Crossref
Crossref
Irina Debnath, Anne M. Stringer, Sara N. Smith, Emily Bae, Harry L. T. Mobley, Joseph T. Wade & Melanie M. Pearson. (2018) MrpJ Directly Regulates Proteus mirabilis Virulence Factors, Including Fimbriae and Type VI Secretion, during Urinary Tract Infection. Infection and Immunity 86:10.
Crossref
Crossref
A. Huttner & V. Gambillara. (2018) The development and early clinical testing of the ExPEC4V conjugate vaccine against uropathogenic Escherichia coli. Clinical Microbiology and Infection 24:10, pages 1046-1050.
Crossref
Crossref
Wioletta Adamus-Białek, Anna Baraniak, Monika Wawszczak, Stanisław Głuszek, Beata Gad, Klaudia Wróbel, Paulina Bator, Marta Majchrzak & Paweł Parniewski. (2018) The genetic background of antibiotic resistance among clinical uropathogenic Escherichia coli strains. Molecular Biology Reports 45:5, pages 1055-1065.
Crossref
Crossref
Shahla Shahbazi, Mohammad Reza Asadi Karam, Mehri Habibi, Atefeh Talebi & Saeid Bouzari. (2018) Distribution of extended-spectrum β-lactam, quinolone and carbapenem resistance genes, and genetic diversity among uropathogenic Escherichia coli isolates in Tehran, Iran. Journal of Global Antimicrobial Resistance 14, pages 118-125.
Crossref
Crossref
Mostafa Rezaee, Sobhan Ghafourian, Fatemeh Sayehmiri, Reza Pakzad, Saeid Safiri & Iraj Pakzad. (2018) Prevalence of Cotrimoxazole Resistance Uropathogenic Bacteria in Iran: A Systematic Review and Meta-Analysis. Archives of Clinical Infectious Diseases 13:5.
Crossref
Crossref
Suhanya Duraiswamy, Jacqueline L. Y. Chee, Siyi Chen, Enjun Yang, Kristin Lees & Swaine L. Chen. (2018) Purification of Intracellular Bacterial Communities during Experimental Urinary Tract Infection Reveals an Abundant and Viable Bacterial Reservoir. Infection and Immunity 86:4.
Crossref
Crossref
Mehri Habibi, Mohammad Reza Asadi Karam & Saeid Bouzari. (2018) Construction and evaluation of the immune protection of a recombinant divalent protein composed of the MrpA from MR/P fimbriae and flagellin of Proteus mirabilis strain against urinary tract infection. Microbial Pathogenesis 117, pages 348-355.
Crossref
Crossref
Tianyuan Yan, Chenxia Liu, Yingxia Li, Wei Xiao, Yating Li & Shuhui Wang. (2018) Prevalence and predictive factors of urinary tract infection among patients with stroke: A meta-analysis. American Journal of Infection Control 46:4, pages 402-409.
Crossref
Crossref
Lana Dbeibo, Julia J. van Rensburg, Sara N. Smith, Kate R. Fortney, Dharanesh Gangaiah, Hongyu Gao, Juan Marzoa, Yunlong Liu, Harry L. T. Mobley & Stanley M. Spinola. (2018) Evaluation of CpxRA as a Therapeutic Target for Uropathogenic Escherichia coli Infections. Infection and Immunity 86:3.
Crossref
Crossref
Janaki Kannan Iyer, Alexia Dickey, Parvaneh Rouhani, Anil Kaul, Nirmal Govindaraju, Raj Narain Singh & Rashmi Kaul. (2018) Nanodiamonds facilitate killing of intracellular uropathogenic E. coli in an in vitro model of urinary tract infection pathogenesis. PLOS ONE 13:1, pages e0191020.
Crossref
Crossref
Bryan Tungland. 2018. Human Microbiota in Health and Disease. Human Microbiota in Health and Disease
605
647
.
Muhammad Rasheed & Arndt van Ophoven. 2018. Neuro-Urology. Neuro-Urology
249
281
.
Barbara Nesta & Mariagrazia Pizza. 2018. Escherichia coli, a Versatile Pathogen. Escherichia coli, a Versatile Pathogen
213
242
.
Mehri Habibi, Mohammad Reza Asadi Karam & Saeid Bouzari. (2017) Evaluation of prevalence, immunogenicity and efficacy of FyuA iron receptor in uropathogenic Escherichia coli isolates as a vaccine target against urinary tract infection. Microbial Pathogenesis 110, pages 477-483.
Crossref
Crossref
Yoshitaka Aoki, Heidi W. Brown, Linda Brubaker, Jean Nicolas Cornu, J. Oliver Daly & Rufus Cartwright. (2017) Urinary incontinence in women. Nature Reviews Disease Primers 3:1.
Crossref
Crossref
Stephen J. Savarino, Robin McKenzie, David R. Tribble, Chad K. Porter, Aisling O’Dowd, Joyce A. Cantrell, Stephanie A. Sincock, Steven T. Poole, Barbara DeNearing, Colleen M. Woods, Hye Kim, Shannon L. Grahek, Carl Brinkley, Joseph H. Crabb & A. Louis Bourgeois. (2017) Prophylactic Efficacy of Hyperimmune Bovine Colostral Antiadhesin Antibodies Against Enterotoxigenic Escherichia coli Diarrhea: A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial. The Journal of Infectious Diseases 216:1, pages 7-13.
Crossref
Crossref
Barbara Osamwonyi & Charlotte Foley. (2017) Management of recurrent urinary tract infections in adults. Surgery (Oxford) 35:6, pages 299-305.
Crossref
Crossref
G. Magistro, J. Marcon, S. Schubert, C. Gratzke & C. G. Stief. (2017) Pathogenese der HarnwegsinfektionPathogenesis of urinary tract infections. Der Urologe 56:6, pages 720-727.
Crossref
Crossref
Paula Pietrucha-Dilanchian & Thomas M. Hooton. 2017. Urinary Tract Infections. Urinary Tract Infections
41
68
.
Ines Ambite, Karoly Nagy, Gabriela Godaly, Manoj Puthia, Björn Wullt & Catharina Svanborg. 2017. Urinary Tract Infections. Urinary Tract Infections
523
554
.
Jessica N. Schaffer & Melanie M. Pearson. 2017. Urinary Tract Infections. Urinary Tract Infections
383
433
.
Shivangi Sachdeva, Raghuvamsi V. Palur, Karpagam U. Sudhakar & Thenmalarchelvi Rathinavelan. (2017) E. coli Group 1 Capsular Polysaccharide Exportation Nanomachinary as a Plausible Antivirulence Target in the Perspective of Emerging Antimicrobial Resistance. Frontiers in Microbiology 8.
Crossref
Crossref
Paula Pietrucha-Dilanchian & Thomas M. Hooton. (2016) Diagnosis, Treatment, and Prevention of Urinary Tract Infection. Microbiology Spectrum 4:6.
Crossref
Crossref
Hongnga T. Le & Booki Min. (2016) Precision Targeting: Mast Cells Wipe Out Infected Bladder Epithelia. Immunity 45:6, pages 1179-1181.
Crossref
Crossref
Laura A. Mike, Sara N. Smith, Christopher A. Sumner, Kathryn A. Eaton & Harry L. T. Mobley. (2016)
Siderophore vaccine conjugates protect against uropathogenic
Escherichia coli
urinary tract infection
. Proceedings of the National Academy of Sciences 113:47, pages 13468-13473.
Crossref
Crossref
Mohsen Heidary, Aghil Bahramian, Ali Hashemi, Mehdi Goudarzi, Vahid Fallah Omrani, Gita Eslami & Hossein Goudarzi. (2016) Detection of acrA, acrB, aac(6′)-Ib-cr, and qepA genes among clinical isolates of Escherichia coli and Klebsiella pneumoniae. Acta Microbiologica et Immunologica Hungarica 64:1, pages 63-69.
Crossref
Crossref
Víctor M. Luna-Pineda, Juan Pablo Reyes-Grajeda, Ariadnna Cruz-Córdova, Zeus Saldaña-Ahuactzi, Sara A. Ochoa, Carmen Maldonado-Bernal, Vicenta Cázares-Domínguez, Leticia Moreno-Fierros, José Arellano-Galindo, Rigoberto Hernández-Castro & Juan Xicohtencatl-Cortes. (2016) Dimeric and Trimeric Fusion Proteins Generated with Fimbrial Adhesins of Uropathogenic Escherichia coli. Frontiers in Cellular and Infection Microbiology 6.
Crossref
Crossref
Lendl Tan, Danilo G. Moriel, Makrina Totsika, Scott A. Beatson & Mark A. Schembri. (2016) Differential Regulation of the Surface-Exposed and Secreted SslE Lipoprotein in Extraintestinal Pathogenic Escherichia coli. PLOS ONE 11:9, pages e0162391.
Crossref
Crossref
Mohammad Reza Asadi Karam, Mehri Habibi & Saeid Bouzari. (2016) Use of flagellin and cholera toxin as adjuvants in intranasal vaccination of mice to enhance protective immune responses against uropathogenic Escherichia coli antigens. Biologicals 44:5, pages 378-386.
Crossref
Crossref
Matthieu Galtier, Luisa De Sordi, Damien Maura, Harindra Arachchi, Stevenn Volant, Marie‐Agnès Dillies & Laurent Debarbieux. (2016) Bacteriophages to reduce gut carriage of antibiotic resistant uropathogens with low impact on microbiota composition. Environmental Microbiology 18:7, pages 2237-2245.
Crossref
Crossref
Ines Ambite, Karoly Nagy, Gabriela Godaly, Manoj Puthia, Björn Wullt & Catharina Svanborg. (2016) Susceptibility to Urinary Tract Infection: Benefits and Hazards of the Antibacterial Host Response. Microbiology Spectrum 4:3.
Crossref
Crossref
Danilo G. Moriel, Begoña Heras, Jason J. Paxman, Alvin W. Lo, Lendl Tan, Matthew J. Sullivan, Samantha J. Dando, Scott A. Beatson, Glen C. Ulett & Mark A. Schembri. (2016) Molecular and Structural Characterization of a Novel Escherichia coli Interleukin Receptor Mimic Protein. mBio 7:2.
Crossref
Crossref
Karellen Beren García Méndez, Gabriel Bragagnolo, David O'Callaghan, Jean-Philippe Lavigne & Anne Keriel. (2016)
A high-throughput assay for the measurement of uropathogenic
Escherichia coli
attachment to urinary bladder cells
. International Journal of Experimental Pathology 97:2, pages 194-201.
Crossref
Crossref
Gregor Reid. 2016. The Role of Bacteria in Urology. The Role of Bacteria in Urology
1
6
.
Harry Mobley & Christopher Alteri. (2015) Development of a Vaccine against Escherichia coli Urinary Tract Infections. Pathogens 5:1, pages 1.
Crossref
Crossref
Kaveri S. Parker, James D. Wilson, Jonas Marschall, Peter J. Mucha & Jeffrey P. Henderson. (2015) Network Analysis Reveals Sex- and Antibiotic Resistance-Associated Antivirulence Targets in Clinical Uropathogens. ACS Infectious Diseases 1:11, pages 523-532.
Crossref
Crossref
Hosam M. Zowawi, Patrick N. A. Harris, Matthew J. Roberts, Paul A. Tambyah, Mark A. Schembri, M. Diletta Pezzani, Deborah A. Williamson & David L. Paterson. (2015) The emerging threat of multidrug-resistant Gram-negative bacteria in urology. Nature Reviews Urology 12:10, pages 570-584.
Crossref
Crossref
Soman N. Abraham & Yuxuan Miao. (2015) The nature of immune responses to urinary tract infections. Nature Reviews Immunology 15:10, pages 655-663.
Crossref
Crossref
Jessica N. Schaffer & Melanie M. Pearson. (2015)
Proteus mirabilis
and Urinary Tract Infections
. Microbiology Spectrum 3:5.
Crossref
Crossref
Mehri Habibi, Mohammad Reza Asadi Karam & Saeid Bouzari. (2015) Evaluation of the effect of MPL and delivery route on immunogenicity and protectivity of different formulations of FimH and MrpH from uropathogenic Escherichia coli and Proteus mirabilis in a UTI mouse model. International Immunopharmacology 28:1, pages 70-78.
Crossref
Crossref
Ariel R. Brumbaugh, Sara N. Smith, Sargurunathan Subashchandrabose, Stephanie D. Himpsl, Tracy H. Hazen, David A. Rasko & Harry L. T. Mobley. (2015) Blocking Yersiniabactin Import Attenuates Extraintestinal Pathogenic Escherichia coli in Cystitis and Pyelonephritis and Represents a Novel Target To Prevent Urinary Tract Infection. Infection and Immunity 83:4, pages 1443-1450.
Crossref
Crossref
Mehri Habibi, Mohammad Reza Asadi Karam, Mohammad Ali Shokrgozar, Mana Oloomi, Anis Jafari & Saeid Bouzari. (2015) Intranasal immunization with fusion protein MrpH·FimH and MPL adjuvant confers protection against urinary tract infections caused by uropathogenic Escherichia coli and Proteus mirabilis. Molecular Immunology 64:2, pages 285-294.
Crossref
Crossref
Fernando Baquero, Val F. Lanza, Rafael Cantón & Teresa M. Coque. (2014) Public health evolutionary biology of antimicrobial resistance: priorities for intervention. Evolutionary Applications 8:3, pages 223-239.
Crossref
Crossref
Foroogh Neamati, Farzaneh Firoozeh, Mahmood Saffari & Mohammad Zibaei. (2015) Virulence Genes and Antimicrobial Resistance Pattern in Uropathogenic Escherichia coli Isolated From Hospitalized Patients in Kashan, Iran. Jundishapur Journal of Microbiology 8:2.
Crossref
Crossref
Florian M.E. Wagenlehner, Stefania Ballarini, Adrian Pilatz, Wolfgang Weidner, Lorenz Lehr & Kurt G. Naber. (2015) A Randomized, Double-Blind, Parallel-Group, Multicenter Clinical Study of <b><i>Escherichia coli</i></b>-Lyophilized Lysate for the Prophylaxis of Recurrent Uncomplicated Urinary Tract Infections. Urologia Internationalis 95:2, pages 167-176.
Crossref
Crossref
Ines Ambite, Nataliya Lutay, Gabriela Godaly & Catharina Svanborg. 2015. Mucosal Immunology. Mucosal Immunology
2039
2058
.
Patrick D. Olson, Sheryl S. Justice & David A. Hunstad. 2015. Molecular Medical Microbiology. Molecular Medical Microbiology
1373
1387
.
Dana Cialla, Sibyll Pollok, Carolin Steinbrücker, Karina Weber & Jürgen Popp. (2014) SERS-based detection of biomolecules. Nanophotonics 3:6, pages 383-411.
Crossref
Crossref
Gaëlle Porcheron, Rima Habib, Sébastien Houle, Mélissa Caza, François Lépine, France Daigle, Eric Massé & Charles M. Dozois. (2014) The Small RNA RyhB Contributes to Siderophore Production and Virulence of Uropathogenic Escherichia coli. Infection and Immunity 82:12, pages 5056-5068.
Crossref
Crossref
Lindsey Cox & Anne P. Cameron. (2014) Prevention of Urinary Tract Infection for Patients with Neurogenic Bladder. Current Bladder Dysfunction Reports 9:4, pages 282-288.
Crossref
Crossref
Thomas J. Hannan, Pacita L. Roberts, Terrence E. Riehl, Sjoerd van der Post, Jana M. Binkley, Drew J. Schwartz, Hiroyuki Miyoshi, Matthias Mack, Reto A. Schwendener, Thomas M. Hooton, Thaddeus S. Stappenbeck, Gunnar C. Hansson, William F. Stenson, Marco Colonna, Ann E. Stapleton & Scott J. Hultgren. (2014) Inhibition of Cyclooxygenase-2 Prevents Chronic and Recurrent Cystitis. EBioMedicine 1:1, pages 46-57.
Crossref
Crossref
Hiroki Ando, Robert Citorik, Sara Cleto, Sebastien Lemire, Mark Mimee & Timothy Lu. 2014. Novel Antimicrobial Agents and Strategies. Novel Antimicrobial Agents and Strategies
109
180
.
Stella Cascioferro, Maria Grazia Cusimano & Domenico Schillaci. (2014) Antiadhesion agents against Gram-positive pathogens. Future Microbiology 9:10, pages 1209-1220.
Crossref
Crossref
Alain L. Servin. (2014) Pathogenesis of Human Diffusely Adhering Escherichia coli Expressing Afa/Dr Adhesins (Afa/Dr DAEC): Current Insights and Future Challenges. Clinical Microbiology Reviews 27:4, pages 823-869.
Crossref
Crossref
Jie Li & Xiao-yan Yuan. (2014) Identification of Corynebacterium urealyticum based on the phenotypic characteristics and 16S rRNA gene sequence. Reviews in Medical Microbiology 25:4, pages 126-128.
Crossref
Crossref
Andrew Chetwood, Nicholas Drinnan & Amr M Emara. (2014) Persistent Urinary Tract Infections: Prevention and Management. Current Bladder Dysfunction Reports 9:3, pages 151-155.
Crossref
Crossref
Stefan Miladinov Kovachev. (2014) Obstetric and Gynecological Diseases and Complications Resulting from Vaginal Dysbacteriosis. Microbial Ecology 68:2, pages 173-184.
Crossref
Crossref
Jaklien C. Leemans, Lotte Kors, Hans-Joachim Anders & Sandrine Florquin. (2014) Pattern recognition receptors and the inflammasome in kidney disease. Nature Reviews Nephrology 10:7, pages 398-414.
Crossref
Crossref
Kate H. Moore & Anna P. Malykhina. (2014) What is the role of covert infection in detrusor overactivity, and other LUTD? ICI-RS 2013. Neurourology and Urodynamics 33:5, pages 606-610.
Crossref
Crossref
Barbara Nesta, Maria Valeri, Angela Spagnuolo, Roberto Rosini, Marirosa Mora, Paolo Donato, Christopher J. Alteri, Mariangela Del Vecchio, Scilla Buccato, Alfredo Pezzicoli, Isabella Bertoldi, Lapo Buzzigoli, Giovanna Tuscano, Maria Falduto, Valentina Rippa, Yaqoub Ashhab, Giuliano Bensi, Maria Rita Fontana, Kate L. Seib, Harry L. T. Mobley, Mariagrazia Pizza, Marco Soriani & Laura Serino. (2014) SslE Elicits Functional Antibodies That Impair In Vitro Mucinase Activity and In Vivo Colonization by Both Intestinal and Extraintestinal Escherichia coli Strains. PLoS Pathogens 10:5, pages e1004124.
Crossref
Crossref
V.G. FowlerJrJr & R.A. Proctor. (2014) Where does a Staphylococcus aureus vaccine stand?. Clinical Microbiology and Infection 20, pages 66-75.
Crossref
Crossref
A. Reisner, M. Maierl, M. Jorger, R. Krause, D. Berger, A. Haid, D. Tesic & E. L. Zechner. (2013) Type 1 Fimbriae Contribute to Catheter-Associated Urinary Tract Infections Caused by Escherichia coli. Journal of Bacteriology 196:5, pages 931-939.
Crossref
Crossref
Ann E. Stapleton. (2014) Urinary Tract Infection Pathogenesis. Infectious Disease Clinics of North America 28:1, pages 149-159.
Crossref
Crossref
Steven L. Percival & David W. Williams. 2014. Microbiology of Waterborne Diseases. Microbiology of Waterborne Diseases
89
117
.
K.M. Stemler & I.U. Mysorekar. 2014. Pathobiology of Human Disease. Pathobiology of Human Disease
2914
2922
.
Sargurunathan Subashchandrabose, Sara N. Smith, Rachel R. Spurbeck, Monica M. Kole & Harry L. T. Mobley. (2013) Genome-Wide Detection of Fitness Genes in Uropathogenic Escherichia coli during Systemic Infection. PLoS Pathogens 9:12, pages e1003788.
Crossref
Crossref
Nerino Allocati, Michele Masulli, Mikhail Alexeyev & Carmine Di Ilio. (2013) Escherichia coli in Europe: An Overview. International Journal of Environmental Research and Public Health 10:12, pages 6235-6254.
Crossref
Crossref
F. Bruyère, J.-P. Boiteux, A. Sotto, G. Karsenty, C. Bastide, L. Guy & J.-P. Lavigne. (2013) Les traitements anti-infectieux non médicamenteux en urologie. Progrès en Urologie 23:15, pages 1357-1364.
Crossref
Crossref
Jennifer A. Silverman, Henry L. SchreiberIVIV, Thomas M. Hooton & Scott J. Hultgren. (2013) From Physiology to Pharmacy: Developments in the Pathogenesis and Treatment of Recurrent Urinary Tract Infections. Current Urology Reports 14:5, pages 448-456.
Crossref
Crossref
Claudia Fessele & Thisbe Lindhorst. (2013) Effect of Aminophenyl and Aminothiahexyl α-D-Glycosides of the Manno-, Gluco-, and Galacto-Series on Type 1 Fimbriae-Mediated Adhesion of Escherichia coli. Biology 2:3, pages 1135-1149.
Crossref
Crossref
Ariel R. Brumbaugh, Sara N. Smith & Harry L. T. Mobley. (2013) Immunization with the Yersiniabactin Receptor, FyuA, Protects against Pyelonephritis in a Murine Model of Urinary Tract Infection. Infection and Immunity 81:9, pages 3309-3316.
Crossref
Crossref
Alina Wang, Parminder Nizran, Michael A. Malone & Timothy Riley. (2013) Urinary Tract Infections. Primary Care: Clinics in Office Practice 40:3, pages 687-706.
Crossref
Crossref
Sargurunathan Subashchandrabose, Tracy H. Hazen, David A. Rasko & Harry L. T. Mobley. (2013)
Draft genome sequences of five recent human uropathogenic
Escherichia coli
isolates
. Pathogens and Disease, pages n/a-n/a.
Crossref
Crossref
David Lebeaux, Ashwini Chauhan, Olaya Rendueles & Christophe Beloin. (2013) From in vitro to in vivo Models of Bacterial Biofilm-Related Infections. Pathogens 2:2, pages 288-356.
Crossref
Crossref
Betsy Foxman & Miatta Buxton. (2013) Alternative Approaches to Conventional Treatment of Acute Uncomplicated Urinary Tract Infection in Women. Current Infectious Disease Reports 15:2, pages 124-129.
Crossref
Crossref
Nafiseh Esmaili, Hossein Mortazavi, Pedram Noormohammadpour, Majid Boreiri, Tahereh Soori, Iman Vasheghani Farahani & Mitra Mohit. (2013) Pemphigus Vulgaris and Infections: A Retrospective Study on 155 Patients. Autoimmune Diseases 2013, pages 1-5.
Crossref
Crossref